HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Lys(15)-Arg(16)-Leu(27)- vasoactive intestinal peptide (1-7)-GRF (8-27)

a VIP(1)-R-selective ligand and VPAC2 agonist
Also Known As:
vasoactive intestinal peptide (1-7)-GRF (8-27), Lys(15)-Arg(16)-Leu(27)-; (Lys(15),Arg(16),Leu(27))VIP-(1-7)-GRF-(8-27); 15-Lys-16-Arg-27-Leu-VIP-(1-7)-GRF-(8-27); BAY 55-9837; BAY-55-9837; KRLVIP(1-7)GRF(8-27); VIP-(1-7)-GRF-(8-27), lysyl(15)-arginyl(16)-leucyl(27)-
Networked: 3 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hong, An: 1 article (01/2014)
2. Ma, Yi: 1 article (01/2014)
3. Wang, Yayu: 1 article (01/2014)
4. Luo, Tianjie: 1 article (01/2014)
5. MacKenzie, Alex: 1 article (01/2014)
6. Holcik, Martin: 1 article (01/2014)
7. Zhuang, Manjiao: 1 article (01/2014)
8. MacKenzie, Duncan: 1 article (01/2014)
9. Hadwen, Jeremiah: 1 article (01/2014)
10. Rao, Lei: 1 article (01/2014)

Related Diseases

1. Stroke (Strokes)
2. Type 2 Diabetes Mellitus (MODY)
3. Intracranial Hemorrhages (Intracranial Hemorrhage)
4. Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
5. Spinal Muscular Atrophy (Progressive Muscular Atrophy)

Related Drugs and Biologics

1. Type II Vasoactive Intestinal Peptide Receptors
2. Chitosan
3. Selenium